Not convinced our premier meeting is the room to network with peers in the dermatology community?
Take a look at what last year’s attendee said about our meeting:
Great discussion, very good selection of topics and well balance of speakers. - Principal Scientist
Research, AbbVie
The small format and opportunity for networking: easy to find people, nice conference environment with couches and coffee tables, and small lunch and standing tables that made it easy to approach people and start conversation
Director - Global Programs, Affibody AB
The small size enabled greater intimacy, with more networking opportunities and interactive Q&A during the presentations compared to larger conferences
CEO & CSO, Alvino Therapeutics
Extremely intimate group of experts so very easy to network and make connections. Very focused topics
Preclinical Manager, Aquestive Therapeutics
It's a focused meeting. It's short and to the point. The speed networking the first morning really breaks the ice. Boston is a good location
Business Development Manager, Contract Pharmaceuticals Limited
Good size, so plenty of opportunities to talk with speakers and other participants. Good mix of early and later stage therapeutics
Head of Translational Medicine, Engimmune Therapeutics
A good representation of the current situation and market needs
Advisor, Molecular Medicine Research Institute
I like the small size of the event. It allows to connect and have in-depth discussions. I truly enjoyed hearing the presentations of early-stage companies
Vice President, Head of Commercial, Nielsen BioSciences
Very well organized & the right diversity of speakers & subjects
Senior Dermatology Advisor, Nogra Pharma
The networking sessions were great and the topics presented at the sessions were relevant in the current field
Associate Director, Strategic Alliances & Business Development, Nordic Bioscience
You had all the right people in attendance
CEO, Precefi
Participation of many large pharma in dermatology
CSO, TIRmed
Explore the Agenda to Discover the Translational to Access Priorities Shaping Dermatology R&D in 2026
Explore a focused agenda of scientific case studies, expert panels and interactive discussions designed to help you discover novel targets, improve translational confidence, optimize clinical development, differentiate therapies and accelerate the next generation of dermatology innovation across both common and rare inflammatory skin diseases.
Partner to Position Your Solutions at the Centre of Active Dermatology Pipelines
Partner with the summit to showcase your capabilities to senior pharma and biotech teams actively seeking support across biomarkers, imaging, clinical trials, manufacturing and formulation.
Join Biopharma Experts to Connect with the Decision-Makers Driving Dermatology Development Forward
Join a global audience of 90+ senior leaders from pharma and biotech for high-value networking, candid peer exchange and relationship-building across preclinical and late-stage development, access and launch.